-
Mashup Score: 2A call for community-shared decisions - 1 year(s) ago
Shared decision-making in medicine is widely viewed as a collaboration between the patient and the clinician. For example, Montori et al state, ‘The patient and clinician must collaborate to arrive at a useful formulation of the problem’.1 Patients are encouraged to evaluate care choices in light of the benefits and harms of each, state their preferences and identify the best course of action along with their doctor.2 Despite its broad reach, shared decision-making solely between a patient and doctor has clear limits. Over 30 years ago, Brock and Wartman cautioned that ‘[p]atients do not have an unqualified right to make even rational individual choices that risk serious harm to others’.3 Elywin et al noted that ‘limits on shared decision-making will occur when… wider interests overrule individual wishes’.4 These authors lay out problems with shared decisions for antibiotics, opioids and vaccine hesitancy. A crucial gap is how to address these problems in practice. Antibiotic-resistant
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 1A call for community-shared decisions - 1 year(s) ago
Shared decision-making in medicine is widely viewed as a collaboration between the patient and the clinician. For example, Montori et al state, ‘The patient and clinician must collaborate to arrive at a useful formulation of the problem’.1 Patients are encouraged to evaluate care choices in light of the benefits and harms of each, state their preferences and identify the best course of action along with their doctor.2 Despite its broad reach, shared decision-making solely between a patient and doctor has clear limits. Over 30 years ago, Brock and Wartman cautioned that ‘[p]atients do not have an unqualified right to make even rational individual choices that risk serious harm to others’.3 Elywin et al noted that ‘limits on shared decision-making will occur when… wider interests overrule individual wishes’.4 These authors lay out problems with shared decisions for antibiotics, opioids and vaccine hesitancy. A crucial gap is how to address these problems in practice. Antibiotic-resistant
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 7
Cardiovascular disease (CVD) continues to exert a heavy burden in most countries in the world, with high blood pressure continuing to be one of the most important drivers of this burden. The urgency to tackle CVD has never been clearer. WHO launched a global effort (the Global Hearts Initiative) with five technical packages aimed at targeting major drivers of the CVD burden, including actions on tobacco (MPOWER), physical activity (ACTIVE), some aspects of diet such as reducing salt (SHAKE) and trans fats intake (REPLACE) and HEARTS. HEARTS is a set of activities to improve cardiovascular risk management in primary care, with a focus on high blood pressure.1 The HEARTS technical package is an institutionalised model of care and a set of guidelines for cardiovascular risk management, focusing on hypertension control and secondary prevention in primary healthcare. HEARTS is structured around six pillars, focusing on treatment and medication protocols, better quality blood pressure measur
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 1A call for community-shared decisions - 1 year(s) ago
Shared decision-making in medicine is widely viewed as a collaboration between the patient and the clinician. For example, Montori et al state, ‘The patient and clinician must collaborate to arrive at a useful formulation of the problem’.1 Patients are encouraged to evaluate care choices in light of the benefits and harms of each, state their preferences and identify the best course of action along with their doctor.2 Despite its broad reach, shared decision-making solely between a patient and doctor has clear limits. Over 30 years ago, Brock and Wartman cautioned that ‘[p]atients do not have an unqualified right to make even rational individual choices that risk serious harm to others’.3 Elywin et al noted that ‘limits on shared decision-making will occur when… wider interests overrule individual wishes’.4 These authors lay out problems with shared decisions for antibiotics, opioids and vaccine hesitancy. A crucial gap is how to address these problems in practice. Antibiotic-resistant
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6
Cardiovascular disease (CVD) continues to exert a heavy burden in most countries in the world, with high blood pressure continuing to be one of the most important drivers of this burden. The urgency to tackle CVD has never been clearer. WHO launched a global effort (the Global Hearts Initiative) with five technical packages aimed at targeting major drivers of the CVD burden, including actions on tobacco (MPOWER), physical activity (ACTIVE), some aspects of diet such as reducing salt (SHAKE) and trans fats intake (REPLACE) and HEARTS. HEARTS is a set of activities to improve cardiovascular risk management in primary care, with a focus on high blood pressure.1 The HEARTS technical package is an institutionalised model of care and a set of guidelines for cardiovascular risk management, focusing on hypertension control and secondary prevention in primary healthcare. HEARTS is structured around six pillars, focusing on treatment and medication protocols, better quality blood pressure measur
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 6
Cardiovascular disease (CVD) continues to exert a heavy burden in most countries in the world, with high blood pressure continuing to be one of the most important drivers of this burden. The urgency to tackle CVD has never been clearer. WHO launched a global effort (the Global Hearts Initiative) with five technical packages aimed at targeting major drivers of the CVD burden, including actions on tobacco (MPOWER), physical activity (ACTIVE), some aspects of diet such as reducing salt (SHAKE) and trans fats intake (REPLACE) and HEARTS. HEARTS is a set of activities to improve cardiovascular risk management in primary care, with a focus on high blood pressure.1 The HEARTS technical package is an institutionalised model of care and a set of guidelines for cardiovascular risk management, focusing on hypertension control and secondary prevention in primary healthcare. HEARTS is structured around six pillars, focusing on treatment and medication protocols, better quality blood pressure measur
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 25Reporting health and medical research - 1 year(s) ago
The use of the best available evidence to inform patient care in evidence-based medicine is reliant on the accurate, complete and transparent reporting of health and medical research. Without a complete and transparent account of what was done and what was found during a research study, findings cannot be fully understood, replicated, assessed for validity and applicability, and used to inform clinical and policy decisions. For over 50 years, problems of incomplete and poor reporting of research have been widely documented across health and medical research.1–3 Unusable research reports contribute to avoidable research waste4 through the inability to appraise and synthesise research and can detrimentally impact patient care through incorrect implementation of research findings.5 Because of this, complete and transparent reporting of research is a researcher’s moral and ethical responsibility to maximise the usefulness and positive impact of their research.6 Our objective in this articl
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 4
Cardiovascular disease (CVD) continues to exert a heavy burden in most countries in the world, with high blood pressure continuing to be one of the most important drivers of this burden. The urgency to tackle CVD has never been clearer. WHO launched a global effort (the Global Hearts Initiative) with five technical packages aimed at targeting major drivers of the CVD burden, including actions on tobacco (MPOWER), physical activity (ACTIVE), some aspects of diet such as reducing salt (SHAKE) and trans fats intake (REPLACE) and HEARTS. HEARTS is a set of activities to improve cardiovascular risk management in primary care, with a focus on high blood pressure.1 The HEARTS technical package is an institutionalised model of care and a set of guidelines for cardiovascular risk management, focusing on hypertension control and secondary prevention in primary healthcare. HEARTS is structured around six pillars, focusing on treatment and medication protocols, better quality blood pressure measur
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 25Reporting health and medical research - 1 year(s) ago
The use of the best available evidence to inform patient care in evidence-based medicine is reliant on the accurate, complete and transparent reporting of health and medical research. Without a complete and transparent account of what was done and what was found during a research study, findings cannot be fully understood, replicated, assessed for validity and applicability, and used to inform clinical and policy decisions. For over 50 years, problems of incomplete and poor reporting of research have been widely documented across health and medical research.1–3 Unusable research reports contribute to avoidable research waste4 through the inability to appraise and synthesise research and can detrimentally impact patient care through incorrect implementation of research findings.5 Because of this, complete and transparent reporting of research is a researcher’s moral and ethical responsibility to maximise the usefulness and positive impact of their research.6 Our objective in this articl
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
-
Mashup Score: 25Reporting health and medical research - 1 year(s) ago
The use of the best available evidence to inform patient care in evidence-based medicine is reliant on the accurate, complete and transparent reporting of health and medical research. Without a complete and transparent account of what was done and what was found during a research study, findings cannot be fully understood, replicated, assessed for validity and applicability, and used to inform clinical and policy decisions. For over 50 years, problems of incomplete and poor reporting of research have been widely documented across health and medical research.1–3 Unusable research reports contribute to avoidable research waste4 through the inability to appraise and synthesise research and can detrimentally impact patient care through incorrect implementation of research findings.5 Because of this, complete and transparent reporting of research is a researcher’s moral and ethical responsibility to maximise the usefulness and positive impact of their research.6 Our objective in this articl
Source: ebm.bmj.comCategories: General Medicine News, PayerTweet
A call for community-shared decisions #Analysis by Doctor et al. Link: https://t.co/pHcZCl7nF6 https://t.co/pCOW3147Iy